My NCBISign In
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer
Andrew E Teschendorff, Ahmad Miremadi, Sarah E Pinder, Ian O Ellis, Carlos Caldas
Genome Biol. 2007; 8(8): R157. Published online 2007 August 2. doi: 10.1186/gb-2007-8-8-r157
PMCID:
PMC2374988
Abstract Full Text PDF–1.4M Supplementary Material

Is Cited by the Following 52 Articles in this Archive:

Integrated cross-species transcriptional network analysis of metastatic susceptibility
Ying Hu, Gang Wu, Michael Rusch, Luanne Lukes, Kenneth H. Buetow, Jinghui Zhang, Kent W. Hunter
Proc Natl Acad Sci U S A. 2012 February 21; 109(8): 3184–3189. Published online 2012 January 30. doi: 10.1073/pnas.1117872109
PMCID:
PMC3286991
Free in PMC on 2012/08/21
A Gene Signature for Predicting Outcome in Patients with Basal-like Breast Cancer
Robin M. Hallett, Anna Dvorkin-Gheva, Anita Bane, John A. Hassell
Sci Rep. 2012; 2: 227. Published online 2012 January 17. doi: 10.1038/srep00227
PMCID:
PMC3259129
Abstract Full Text PDF–752K Supplementary Material
Basal Breast Cancer: A Complex and Deadly Molecular Subtype
F Bertucci, P Finetti, D Birnbaum
Curr Mol Med. 2012 January; 12(1): 96–110. Published online 2012 January. doi: 10.2174/156652412798376134
PMCID:
PMC3343384
Abstract Full Text PDF–871K
Homogeneous Datasets of Triple Negative Breast Cancers Enable the Identification of Novel Prognostic and Predictive Signatures
Thomas Karn, Lajos Pusztai, Uwe Holtrich, Takayuki Iwamoto, Christine Y. Shiang, Marcus Schmidt, Volkmar Müller, Christine Solbach, Regine Gaetje, Lars Hanker, Andre Ahr, Cornelia Liedtke, Eugen Ruckhäberle, Manfred Kaufmann, Achim Rody
PLoS One. 2011; 6(12): e28403. Published online 2011 December 29. doi: 10.1371/journal.pone.0028403
PMCID:
PMC3248403
Abstract Full Text PDF–761K Supplementary Material
Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer
Nathan R West, Katy Milne, Pauline T Truong, Nicol Macpherson, Brad H Nelson, Peter H Watson
Breast Cancer Res. 2011; 13(6): R126. Published online 2011 December 8. doi: 10.1186/bcr3072
PMCID:
PMC3326568
Abstract Full Text PDF–2.2M Supplementary Material
Cancer cell proliferation is inhibited by specific modulation frequencies
J W Zimmerman, M J Pennison, I Brezovich, N Yi, C T Yang, R Ramaker, D Absher, R M Myers, N Kuster, F P Costa, A Barbault, B Pasche
Br J Cancer. 2012 January 17; 106(2): 307–313. Published online 2011 December 1. doi: 10.1038/bjc.2011.523
PMCID:
PMC3261663
Free in PMC on 2013/01/17
Multiple-input multiple-output causal strategies for gene selection
Gianluca Bontempi, Benjamin Haibe-Kains, Christine Desmedt, Christos Sotiriou, John Quackenbush
BMC Bioinformatics. 2011; 12: 458. Published online 2011 November 25. doi: 10.1186/1471-2105-12-458
PMCID:
PMC3323860
Abstract Full Text PDF–814K Supplementary Material
A clinically relevant gene signature in triple negative and basal-like breast cancer
Achim Rody, Thomas Karn, Cornelia Liedtke, Lajos Pusztai, Eugen Ruckhaeberle, Lars Hanker, Regine Gaetje, Christine Solbach, Andre Ahr, Dirk Metzler, Marcus Schmidt, Volkmar Müller, Uwe Holtrich, Manfred Kaufmann
Breast Cancer Res. 2011; 13(5): R97. Published online 2011 October 6. doi: 10.1186/bcr3035
PMCID:
PMC3262210
Abstract Full Text PDF–3.6M Supplementary Material
Capturing Changes in Gene Expression Dynamics by Gene Set Differential Coordination Analysis
Tianwei Yu, Yun Bai
Genomics. Author manuscript; available in PMC 2012 December 1.
Published in final edited form as: Genomics. 2011 December; 98(6): 469–477. Published online 2011 September 24. doi: 10.1016/j.ygeno.2011.09.001
PMCID:
PMC3224192
Free in PMC on 2012/12/01
Therapeutic Cancer Vaccines and Translating Vaccinomics Science to the Global Health Clinic: Emerging Applications Toward Proof of Concept
Megan M. O'Meara, Mary L. Disis
OMICS. 2011 September; 15(9): 579–588. doi: 10.1089/omi.2010.0149
PMCID:
PMC3166179
Free in PMC on 2012/09/01
Kinome expression profiling and prognosis of basal breast cancers
Renaud Sabatier, Pascal Finetti, Emilie Mamessier, Stéphane Raynaud, Nathalie Cervera, Eric Lambaudie, Jocelyne Jacquemier, Patrice Viens, Daniel Birnbaum, François Bertucci
Mol Cancer. 2011; 10: 86. Published online 2011 July 21. doi: 10.1186/1476-4598-10-86
PMCID:
PMC3156788
Abstract Full Text PDF–553K Supplementary Material
A Methyl-Deviator Epigenotype of Estrogen Receptor–Positive Breast Carcinoma Is Associated with Malignant Biology
J.. Keith Killian, Sven Bilke, Sean Davis, Robert L. Walker, Erich Jaeger, M. Scott Killian, Joshua J. Waterfall, Marina Bibikova, Jian-Bing Fan, William I. Smith, Jr, Paul S. Meltzer
Am J Pathol. 2011 July; 179(1): 55–65. doi: 10.1016/j.ajpath.2011.03.022
PMCID:
PMC3123808
Free in PMC on 2012/07/01
Global MicroRNA Expression Profiling Identifies MiR-210 Associated with Tumor Proliferation, Invasion and Poor Clinical Outcome in Breast Cancer
Françoise Rothé, Michail Ignatiadis, Carole Chaboteaux, Benjamin Haibe-Kains, Naïma Kheddoumi, Samira Majjaj, Bassam Badran, Hussein Fayyad-Kazan, Christine Desmedt, Adrian L. Harris, Martine Piccart, Christos Sotiriou
PLoS One. 2011; 6(6): e20980. Published online 2011 June 29. doi: 10.1371/journal.pone.0020980
PMCID:
PMC3126805
Abstract Full Text PDF–1.0M Supplementary Material
Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction
Pierre-Emmanuel Colombo, Fernanda Milanezi, Britta Weigelt, Jorge S Reis-Filho
Breast Cancer Res. 2011; 13(3): 212. Published online 2011 June 27. doi: 10.1186/bcr2890
PMCID:
PMC3218943
Abstract Full Text PDF–359K
Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1
Jessica L L Robinson, Stewart MacArthur, Caryn S Ross-Innes, Wayne D Tilley, David E Neal, Ian G Mills, Jason S Carroll
EMBO J. 2011 August 3; 30(15): 3019–3027. Published online 2011 June 24. doi: 10.1038/emboj.2011.216
Correction in:
EMBO J. 2012 March 21; 31(6): 1617.
PMCID:
PMC3160190
Free in PMC on 2012/08/03
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann, Joshua A. Bauer, Xi Chen, Melinda E. Sanders, A. Bapsi Chakravarthy, Yu Shyr, Jennifer A. Pietenpol
J Clin Invest. 2011 July 1; 121(7): 2750–2767. Published online 2011 June 1. doi: 10.1172/JCI45014
PMCID:
PMC3127435
Abstract Full Text PDF–5.4M Supplementary Material
Distinctive Responsiveness to Stromal Signaling Accompanies Histologic Grade Programming of Cancer Cells
Maria Gloria Luciani, Junhee Seok, Aejaz Sayeed, Stacey Champion, William H. Goodson, Stefanie S. Jeffrey, Wenzhong Xiao, Michael Mindrinos, Ronald W. Davis, Shanaz H. Dairkee
PLoS One. 2011; 6(5): e20016. Published online 2011 May 19. doi: 10.1371/journal.pone.0020016
PMCID:
PMC3098270
Abstract Full Text PDF–1.5M Supplementary Material
GOBO: Gene Expression-Based Outcome for Breast Cancer Online
Markus Ringnér, Erik Fredlund, Jari Häkkinen, Åke Borg, Johan Staaf
PLoS One. 2011; 6(3): e17911. Published online 2011 March 21. doi: 10.1371/journal.pone.0017911
PMCID:
PMC3061871
Abstract Full Text PDF–971K Supplementary Material
Do Two Machine-Learning Based Prognostic Signatures for Breast Cancer Capture the Same Biological Processes?
Yotam Drier, Eytan Domany
PLoS One. 2011; 6(3): e17795. Published online 2011 March 14. doi: 10.1371/journal.pone.0017795
PMCID:
PMC3056769
Abstract Full Text PDF–107K Supplementary Material
miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors
Espen Enerly, Israel Steinfeld, Kristine Kleivi, Suvi-Katri Leivonen, Miriam R. Aure, Hege G. Russnes, Jo Anders Rønneberg, Hilde Johnsen, Roy Navon, Einar Rødland, Rami Mäkelä, Bjørn Naume, Merja Perälä, Olli Kallioniemi, Vessela N. Kristensen, Zohar Yakhini, Anne-Lise Børresen-Dale
PLoS One. 2011; 6(2): e16915. Published online 2011 February 22. doi: 10.1371/journal.pone.0016915
PMCID:
PMC3043070
Abstract Full Text PDF–2.7M Supplementary Material
Paradoxical relationship between chromosomal instability and survival outcome in cancer
Nicolai J. Birkbak, Aron C. Eklund, Qiyuan Li, Sarah E. McClelland, David Endesfelder, Patrick Tan, Iain B Tan, Andrea L. Richardson, Zoltan Szallasi, Charles Swanton
Cancer Res. Author manuscript; available in PMC 2011 November 15.
Published in final edited form as: Cancer Res. 2011 May 15; 71(10): 3447–3452. Published online 2011 January 26. doi: 10.1158/0008-5472.CAN-10-3667
PMCID:
PMC3096721
Abstract Full Text PDF–404K Supplementary Material
Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures
Cheng Fan, Aleix Prat, Joel S Parker, Yufeng Liu, Lisa A Carey, Melissa A Troester, Charles M Perou
BMC Med Genomics. 2011; 4: 3. Published online 2011 January 9. doi: 10.1186/1755-8794-4-3
PMCID:
PMC3025826
Abstract Full Text PDF–1.5M Supplementary Material
Prognostic gene network modules in breast cancer hold promise
Andrew E Teschendorff, Yan Jiao, Carlos Caldas
Breast Cancer Res. 2010; 12(6): 317. Published online 2010 December 8. doi: 10.1186/bcr2774
PMCID:
PMC3046436
Abstract Full Text PDF–128K
Gene expression profiles of estrogen receptor positive and estrogen receptor negative breast cancers are detectable in histologically normal breast epithelium
Kelly Graham, Xijin Ge, Antonio de las Morenas, Anusri Tripathi, Carol L. Rosenberg
Clin Cancer Res. Author manuscript; available in PMC 2012 January 15.
Published in final edited form as: Clin Cancer Res. 2011 January 15; 17(2): 236–246. Published online 2010 November 8. doi: 10.1158/1078-0432.CCR-10-1369
PMCID:
PMC3059257
Abstract Full Text PDF–1.4M Supplementary Material
Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules
Andrew E Teschendorff, Sergio Gomez, Alex Arenas, Dorraya El-Ashry, Marcus Schmidt, Mathias Gehrmann, Carlos Caldas
BMC Cancer. 2010; 10: 604. Published online 2010 November 4. doi: 10.1186/1471-2407-10-604
PMCID:
PMC2991308
Abstract Full Text PDF–1.9M Supplementary Material
A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer
Christina Yau, Laura Esserman, Dan H Moore, Fred Waldman, John Sninsky, Christopher C Benz
Breast Cancer Res. 2010; 12(5): R85. Published online 2010 October 14. doi: 10.1186/bcr2753
PMCID:
PMC3096978
Abstract Full Text PDF–552K Supplementary Material
Analysing breast cancer microarrays from African Americans using shrinkage-based discriminant analysis
Herbert Pang, Keita Ebisu, Emi Watanabe, Laura Y. Sue, Tiejun Tong
Hum Genomics. Author manuscript; available in PMC 2011 October 1.
Published in final edited form as: Hum Genomics. 2010 October; 5(1): 5–16.
PMCID:
PMC3042882
Abstract Full Text PDF–471K
Enumerating the gene sets in breast cancer, a "direct" alternative to hierarchical clustering
Dwain Mefford, Joel A Mefford
BMC Genomics. 2010; 11: 482. Published online 2010 August 23. doi: 10.1186/1471-2164-11-482
PMCID:
PMC2996978
Abstract Full Text PDF–1.2M Supplementary Material
Increased entropy of signal transduction in the cancer metastasis phenotype
Andrew E Teschendorff, Simone Severini
BMC Syst Biol. 2010; 4: 104. Published online 2010 July 30. doi: 10.1186/1752-0509-4-104
PMCID:
PMC2925356
Abstract Full Text PDF–1.2M Supplementary Material
Relationship and prognostic significance of SPARC and VEGF protein expression in colon cancer
Jian-fang Liang, Hong-kun Wang, Hong Xiao, Ning Li, Cai-xia Cheng, Yu-ze Zhao, Yan-bo Ma, Jian-zhong Gao, Rui-bing Bai, Hui-xia Zheng
J Exp Clin Cancer Res. 2010; 29(1): 71. Published online 2010 June 16. doi: 10.1186/1756-9966-29-71
PMCID:
PMC2895582
Abstract Full Text PDF–1.0M
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk